 ROCKVILLE, Md., Feb. 9, 2022 PRNewswire -- Synthetic Biologics, Inc. NYSE American: SYN, a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that the Company will be presenting at the 2022 BIO CEO Investor Conference being held February 14-17, 2022. 